Agilent 1100 Series Application Note: Isolation of Radiolabeled Drug Metabolites

This Application Note describes the configuration and set up of a purification system for the isolation of radiolabeled drug metabolites from biological samples applied by an injection pump system. Various fraction collection options, for example, time-based fraction collection monitored by a radiochemical detector or peak-based fraction collection on the radiochemical detector signal are described.


Agilent 1100 Series Application Note: Isolation of Radiolabeled Drug Metabolites - cover page
Brand
Agilent
Category
Other
Document type
Application Note
Language
English
Pages
8
File format
PDF
File size
233 KB
Published
02 July, 2012
Updated
30 September, 2023
MD5 checksum
89E5E9A06417465F03D881AD05EA5CF2

About this manual

This document details the setup of a purification system designed to isolate radiolabeled drug metabolites from complex biological matrices like urine. The system utilizes an Agilent 1100 Series purification platform equipped with specific modules, including preparative pumps, a dual-loop autosampler, and fraction collectors.

What's inside

  • Introduction
  • Equipment
  • System configuration
  • Injection pump system
  • Time-based fraction collection
  • Peak-based fraction collection
  • Monitoring with MSD
  • Conclusions

Specifications

Flow rate4 ml/min
Stop time55 min
Injection volume10 mL
Column temperatureambient
DAD wavelength254 nm

Frequently asked questions

What system is described in this note?

The document describes a configuration of the Agilent 1100 Series purification system equipped with an injection pump system.

How are fractions collected in this setup?

Fractions are collected either by time-based fraction collection or by peak-based fraction collection on the signal from a radiochemical detector.

Download PDF (233 KB)

More Agilent Manuals


View all Agilent manuals →